Literature DB >> 35581482

Expression of proliferation-related genes in BM-MSC-treated ALL cells in hypoxia condition is regulated under the influence of epigenetic factors in-vitro.

Xiaoyu Yang1, Yan Wang1, Heshu Sulaiman Rahman2, Talar Ahmad Merza Mohammad3, Amin Daei Sorkhabi4,5, Stanislav Evgenievich Korsakov6, Lakshmi Thangavelu7, Ali Adili8,9, Aila Sarkesh4,5, Rozita Tamjidifar5, Hossein Saeedi5, Ramin Aslaminabad5, Saeed Tarzi5, Morteza Akbari10.   

Abstract

Mesenchymal stem cells affect ALL cell biology under hypoxic conditions. We studied survival, proliferation, expression, and promoter methylation levels of essential genes involved in expanding MOLT-4 cells co-cultured with BM-MSC under the hypoxic condition. Here, MOLT-4 cells were co-cultured with BMMSCs under hypoxic conditions. First, the apoptosis rate was evaluated by Flow cytometry. Then, MOLT-4 cells' proliferation rate was assessed using MTT assay, and the expressions and methylation rates of genes were determined by qRT-PCR and MS-qPCR, respectively. The results showed that although MOLT-4 cells proliferation and survival rates were reduced under hypoxic conditions, this reduction was not statistically significant. Also, we showed that hypoxic conditions caused upregulation of candidate genes and affected their methylation status. Besides, it was revealed that Pontin was downregulated, while KDM3A, SKP2, and AURKA had an upward trend in the presence of MOLT-4 cells plus BM-MSC. The co-culture of leukemia cells with BMMSCs under hypoxic conditions may be a potential therapeutic approach for ALL.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  ALL; BMMSCs; Hypoxia; Methylation; Pontin

Mesh:

Substances:

Year:  2022        PMID: 35581482     DOI: 10.1007/s12032-022-01671-6

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  52 in total

Review 1.  Recommendations for the assessment and management of measurable residual disease in adults with acute lymphoblastic leukemia: A consensus of North American experts.

Authors:  Nicholas J Short; Elias Jabbour; Maher Albitar; Marcos de Lima; Lia Gore; Jeffrey Jorgensen; Aaron C Logan; Jae Park; Farhad Ravandi; Bijal Shah; Jerald Radich; Hagop Kantarjian
Journal:  Am J Hematol       Date:  2018-11-26       Impact factor: 10.047

Review 2.  Adult bone marrow stem/progenitor cells (MSCs) are preconditioned by microenvironmental "niches" in culture: a two-stage hypothesis for regulation of MSC fate.

Authors:  Carl A Gregory; Joni Ylostalo; Darwin J Prockop
Journal:  Sci STKE       Date:  2005-07-26

Review 3.  Questions and Challenges in the Development of Mesenchymal Stromal/Stem Cell-Based Therapies in Veterinary Medicine.

Authors:  Lax R Devireddy; Lynne Boxer; Michael J Myers; Mark Skasko; Rudell Screven
Journal:  Tissue Eng Part B Rev       Date:  2017-02-28       Impact factor: 6.389

Review 4.  Mesenchymal stem cells as the game-changing tools in the treatment of various organs disorders: Mirage or reality?

Authors:  Faroogh Marofi; Ghasem Vahedi; Ali Hasanzadeh; Sadegh Salarinasab; Pishva Arzhanga; Bahareh Khademi; Majid Farshdousti Hagh
Journal:  J Cell Physiol       Date:  2018-09-07       Impact factor: 6.384

Review 5.  The roles of mesenchymal stem cells in tissue repair and disease modification.

Authors:  Tianyi Wu; Yang Liu; Bin Wang; Gang Li
Journal:  Curr Stem Cell Res Ther       Date:  2014       Impact factor: 3.828

Review 6.  Comparative safety and efficacy of tyrosine kinase inhibitors (TKIs) in the treatment setting of different types of leukemia, and different types of adenocarcinoma.

Authors:  Mohammad Hossein Yazdi; Mohammad Ali Faramarzi; Shekoufeh Nikfar; Mohammad Abdollahi
Journal:  Biomed Pharmacother       Date:  2017-10-06       Impact factor: 6.529

Review 7.  Gemtuzumab ozogamicin in acute myeloid leukemia.

Authors:  C D Godwin; R P Gale; R B Walter
Journal:  Leukemia       Date:  2017-06-13       Impact factor: 11.528

Review 8.  Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).

Authors:  Sebastian Giebel; David I Marks; Nicolas Boissel; Frederic Baron; Sabina Chiaretti; Fabio Ciceri; Jan J Cornelissen; Michael Doubek; Jordi Esteve; Adele Fielding; Robin Foa; Norbert-Claude Gorin; Nicola Gökbuget; Helene Hallböök; Dieter Hoelzer; Elena Paravichnikova; Josep-Maria Ribera; Bipin Savani; Anita W Rijneveld; Christoph Schmid; Ulla Wartiovaara-Kautto; Mohamad Mohty; Arnon Nagler; Hervé Dombret
Journal:  Bone Marrow Transplant       Date:  2018-11-01       Impact factor: 5.483

Review 9.  Mesenchymal Stromal/Stem Cells: A New Era in the Cell-Based Targeted Gene Therapy of Cancer.

Authors:  Faroogh Marofi; Ghasem Vahedi; Alireza Biglari; Abdolreza Esmaeilzadeh; Seyyed Shamsadin Athari
Journal:  Front Immunol       Date:  2017-12-18       Impact factor: 7.561

10.  Analysis of Risk Factors of Peripherally Inserted Central Catheter Induced Catheter-related Infection in Patients with Leukemia.

Authors:  Lanlan Zhou; Mingjun Wang; Aping Li
Journal:  Iran J Public Health       Date:  2017-04       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.